New strategies in ovarian cancer treatment
With no dose‑limiting safety issues observed in the first and second patient cohorts, we have advanced to the next cohort to evaluate a 10x higher dose compared with the starting dose.
The review summarizes current treatment strategies for ovarian cancer, including standard platinum‑ and taxane‑based chemotherapy, surgery, targeted therapy and immunotherapy, and evaluates biomarkers and ongoing clinical trials.
Ovarian cancer is a leading cause of gynecologic cancer mortality; effective chemotherapy regimens determine overall survival and quality of life.
Bizonyítékszint: Irányelv / elfogadott gyakorlat. Magas szintű klinikai elfogadottság.
Kapcsolódó jelek
- Scientists discover why cancer drugs don’t work for everyone
- Epithelial ovarian cancer: prevention, diagnosis, and treatment
- Gynecologic Cancer InterGroup Consensus Recommendations on Clinical Research in Ovarian Cancer
- Why anti‑estrogen therapy fails in ovarian cancer, and how to make it work
- Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements